Nasal continuous positive airway pressure (CPAP) is generally recommended for the
treatment of obstructive sleep apnoea. CPAP lowers the cardiovascular morbidity and …

Opinion statement Heart failure is a highly prevalent disorder, with significant economic
impact, and is associated with excess morbidity and mortality. One factor that may contribute …

Sleep apnoea, both central and obstructive disordered breathing, commonly occurs in
patients with heart failure. Obstructive sleep apnoea occurs both in systolic and diastolic …

Obstructive sleep apnoea (OSA) may aggravate heart failure through the mechanisms of
sleep related arousals, systemic hypertension (awake and asleep) and negative …

Obstructive and central sleep apnea are common in heart failure, and may participate in its
progression by exposing the heart to intermittent hypoxia, increased preload and afterload …

Central sleep apnoea (CSA) in congestive heart failure is sleep state dependent and occurs
typically in stages I and II of non‐REM sleep. The pre‐requisites are hypocapnia and some …

Sleep‐disordered breathing—comprising obstructive sleep apnoea (OSA), central sleep
apnoea (CSA), or a combination of the two—is found in over half of heart failure (HF) …

Cheyne-Stokes Respiration (CSR) has long been recognized to be associated with
congestive cardiac failure. It is present in at least 45% of such patients with stable disease …

Sleep apnea and congestive heart failure (CHF) are both common disorders, occurring in
approximately 2% to 4% and 1% of the general middle-aged population, respectively. 4, 96 …

Sleep apnoea is associated with increased mortality and morbidity. The treatment goal is to
reduce the neurocognitive and cardiovascular sequelae. CPAP therapy in sleep apnoea is …